WaveMan · Form 4
667, L.P. insider trades
> Search tickers & screens ⌘K
LIVE

667, L.P. insider trades

667, L.P. has filed 38 Form 4s with the SEC that we hold, for Incyte Corp (INCY) (Director, 10% owner), TScan Therapeutics, Inc. (TCRX) (Director), IGMS (Director, 10% owner) and Kodiak Sciences Inc. (KOD) (Director, 10% owner), among 14 companies in all. Across all of them we count 89 purchases worth $231.9M and 0 sales worth $0 reported on Form 4. None of these purchases or sales is dated in the last 12 months. The largest single trade was a purchase of 881,875 shares of Incyte Corp worth $64.2M, dated 2021-12-17. The first filing on our record is dated 2021-07-22 and the latest 2026-05-22.

Incyte Corp (INCY)

Director, 10% owner · 10 filings · 20 purchases and sales
Trade dateCodeSharesValue as filedFiled
2021-12-15P, purchase reported on Form 4861$58.5K2021-12-17
2021-12-15P, purchase reported on Form 49,352$640.8K2021-12-17
2021-12-15P, purchase reported on Form 436,476$2.5M2021-12-17
2021-12-15P, purchase reported on Form 49,893$694.9K2021-12-17
2021-12-15P, purchase reported on Form 4288,368$20.7M2021-12-17
2021-12-15P, purchase reported on Form 45,382$382.3K2021-12-17
2021-12-16P, purchase reported on Form 4139,612$10.0M2021-12-17
2021-12-16P, purchase reported on Form 429,703$2.1M2021-12-17
2021-12-17P, purchase reported on Form 4193,997$14.1M2021-12-17
2021-12-17P, purchase reported on Form 4881,875$64.2M2021-12-17
2022-03-08P, purchase reported on Form 47,615$538.2K2022-03-10
2022-03-08P, purchase reported on Form 492,385$6.5M2022-03-10
2022-03-09P, purchase reported on Form 45,370$385.1K2022-03-10
2022-03-09P, purchase reported on Form 465,147$4.7M2022-03-10
2022-03-10P, purchase reported on Form 484$6.0K2022-03-10
2022-03-10P, purchase reported on Form 41,017$73.2K2022-03-10
2022-03-10P, purchase reported on Form 414,490$1.1M2022-03-10
2022-03-10P, purchase reported on Form 42,070$148.8K2022-03-10
2022-03-10P, purchase reported on Form 425,107$1.8M2022-03-10
2022-03-10P, purchase reported on Form 4175,795$12.9M2022-03-10

TScan Therapeutics, Inc. (TCRX)

Director · 7 filings · 10 purchases and sales
Trade dateCodeSharesValue as filedFiled
2021-07-20P, purchase reported on Form 4104,698$1.6M2021-07-22
2021-07-20P, purchase reported on Form 41,320,302$19.8M2021-07-22
2022-05-10P, purchase reported on Form 4325,373$553.1K2022-05-12
2022-05-10P, purchase reported on Form 412,769$24.6K2022-05-12
2022-05-10P, purchase reported on Form 495,060$185.4K2022-05-12
2022-05-10P, purchase reported on Form 4758,094$1.5M2022-05-12
2022-05-10P, purchase reported on Form 440,800$69.4K2022-05-12
2022-05-10P, purchase reported on Form 4101,831$196.5K2022-05-12
2022-05-11P, purchase reported on Form 422,983$45.7K2022-05-12
2022-05-11P, purchase reported on Form 42,882$5.7K2022-05-12

IGMS

Director, 10% owner · 5 filings · 0 purchases and sales

No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.

Kodiak Sciences Inc. (KOD)

Director, 10% owner · 3 filings · 10 purchases and sales
Trade dateCodeSharesValue as filedFiled
2021-08-17P, purchase reported on Form 4400$33.9K2021-08-19
2021-08-17P, purchase reported on Form 47,764$667.3K2021-08-19
2021-08-18P, purchase reported on Form 41,100$97.0K2021-08-19
2021-08-18P, purchase reported on Form 412,898$1.1M2021-08-19
2021-08-18P, purchase reported on Form 48,186$719.6K2021-08-19
2021-08-18P, purchase reported on Form 4400$35.9K2021-08-19
2021-08-19P, purchase reported on Form 473,635$6.5M2021-08-19
2021-08-19P, purchase reported on Form 42,968$258.0K2021-08-19
2021-08-19P, purchase reported on Form 44,649$404.8K2021-08-19
2021-08-19P, purchase reported on Form 42,396$209.6K2021-08-19

BeOne Medicines Ltd. (BGNE)

Director, 10% owner · 2 filings · 0 purchases and sales

No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.

SGEN

Director · 2 filings · 0 purchases and sales

No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.

vTv Therapeutics Inc. (VTVT)

Director · 2 filings · 0 purchases and sales

No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.

Acadia Pharmaceuticals INC (ACAD)

Director, 10% owner · 1 filing · 14 purchases and sales
Trade dateCodeSharesValue as filedFiled
2023-05-22P, purchase reported on Form 47,645$187.0K2023-05-24
2023-05-22P, purchase reported on Form 482,148$2.0M2023-05-24
2023-05-22P, purchase reported on Form 43,781$93.8K2023-05-24
2023-05-22P, purchase reported on Form 440,632$1.0M2023-05-24
2023-05-23P, purchase reported on Form 410,858$275.0K2023-05-24
2023-05-23P, purchase reported on Form 4116,672$3.0M2023-05-24
2023-05-23P, purchase reported on Form 46,941$177.3K2023-05-24
2023-05-23P, purchase reported on Form 474,582$1.9M2023-05-24
2023-05-24P, purchase reported on Form 4259,109$6.6M2023-05-24
2023-05-24P, purchase reported on Form 42,688$68.6K2023-05-24
2023-05-24P, purchase reported on Form 428,878$736.7K2023-05-24
2023-05-24P, purchase reported on Form 424,113$618.5K2023-05-24
2023-05-24P, purchase reported on Form 420,304$513.1K2023-05-24
2023-05-24P, purchase reported on Form 4218,171$5.5M2023-05-24

Bicycle Therapeutics PLC (BCYC)

Director, 10% owner · 1 filing · 0 purchases and sales

No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.

Immunocore Holdings plc (IMCR)

Director · 1 filing · 4 purchases and sales
Trade dateCodeSharesValue as filedFiled
2025-03-17P, purchase reported on Form 460,110$1.8M2025-03-19
2025-03-17P, purchase reported on Form 492,349$2.7M2025-03-19
2025-03-17P, purchase reported on Form 48,589$253.9K2025-03-19
2025-03-17P, purchase reported on Form 4646,290$19.2M2025-03-19

Kiniksa Pharmaceuticals International, plc (KNSA)

Director · 1 filing · 0 purchases and sales

No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.

Kymera Therapeutics, Inc. (KYMR)

Director · 1 filing · 1 purchase or sale
Trade dateCodeSharesValue as filedFiled
2024-08-20P, purchase reported on Form 41$462024-08-22

Madrigal Pharmaceuticals, INC. (MDGL)

Director · 1 filing · 30 purchases and sales
Trade dateCodeSharesValue as filedFiled
2023-12-12P, purchase reported on Form 47$1.5K2023-12-14
2023-12-12P, purchase reported on Form 4370$77.2K2023-12-14
2023-12-12P, purchase reported on Form 452$11.0K2023-12-14
2023-12-12P, purchase reported on Form 4648$137.4K2023-12-14
2023-12-12P, purchase reported on Form 415$3.2K2023-12-14
2023-12-12P, purchase reported on Form 4185$39.5K2023-12-14
2023-12-12P, purchase reported on Form 441$8.8K2023-12-14
2023-12-12P, purchase reported on Form 4515$110.1K2023-12-14
2023-12-12P, purchase reported on Form 453$11.4K2023-12-14
2023-12-12P, purchase reported on Form 4668$143.4K2023-12-14
2023-12-12P, purchase reported on Form 4141$30.6K2023-12-14
2023-12-12P, purchase reported on Form 41,769$383.3K2023-12-14
2023-12-12P, purchase reported on Form 415$3.3K2023-12-14
2023-12-12P, purchase reported on Form 4185$40.3K2023-12-14
2023-12-12P, purchase reported on Form 4229$49.9K2023-12-14
2023-12-12P, purchase reported on Form 42,873$626.1K2023-12-14
2023-12-12P, purchase reported on Form 41,195$262.0K2023-12-14
2023-12-12P, purchase reported on Form 415,005$3.3M2023-12-14
2023-12-12P, purchase reported on Form 4352$77.7K2023-12-14
2023-12-12P, purchase reported on Form 44,408$972.6K2023-12-14
2023-12-12P, purchase reported on Form 4308$68.1K2023-12-14
2023-12-12P, purchase reported on Form 43,857$853.3K2023-12-14
2023-12-12P, purchase reported on Form 47$1.4K2023-12-14
2023-12-12P, purchase reported on Form 493$19.1K2023-12-14
2023-12-12P, purchase reported on Form 456$11.5K2023-12-14
2023-12-12P, purchase reported on Form 4708$145.6K2023-12-14
2023-12-12P, purchase reported on Form 452$10.8K2023-12-14
2023-12-12P, purchase reported on Form 4648$134.1K2023-12-14
2023-12-12P, purchase reported on Form 430$6.3K2023-12-14
2023-12-12P, purchase reported on Form 493$19.5K2023-12-14

Prelude Therapeutics Inc (PRLD)

Director, 10% owner · 1 filing · 0 purchases and sales

No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.

Source

Counted from the Form 4 filings this reporting owner (SEC CIK 1551139) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.

Source: U.S. Securities and Exchange Commission (EDGAR) and other official government data · Updated 2026-10-12 · For informational purposes only, not investment advice.
Privacy · Terms